Feasibility of using limited-population-based average R₁₀ for pharmacokinetic modeling of osteosarcoma dynamic contrast-enhanced magnetic resonance imaging data

Retrospective analyses of clinical dynamic contrast-enhanced (DCE) MRI studies may be limited by failure to measure the longitudinal relaxation rate constant (R₁) initially, which is necessary for quantitative analysis. In addition, errors in R₁ estimation in each individual experiment can cause inconsistent results in derivations of pharmacokinetic parameters, K^trans and v_e, by kinetic modeling of the DCE-MRI time course data. A total of 18 patients with lower extremity osteosarcomas underwent multislice DCE-MRI prior to surgery. For the individual R₁ measurement approach, the R₁ time course was obtained using the two-point R₁ determination method. For the average R₁₀ (precontrast R₁) approach, the R₁ time course was derived using the DCE-MRI pulse sequence signal intensity equation and the average R₁₀ value of this population. The whole tumor and histogram median K^trans (0.57±0.37 and 0.45±0.32 min^-1) and v_e (0.59±0.20 and 0.56±0.17) obtained with the individual R₁ measurement approach are not significantly different (paired t test) from those (K^trans: 0.61±0.46 and 0.44±0.33 min^-1; v_e: 0.61±0.19 and 0.55±0.14) obtained with the average R₁₀ approach. The results suggest that it is feasible, as well as practical, to use a limited-population-based average R₁₀ for pharmacokinetic modeling of osteosarcoma DCE-MRI data.